Beuerman
Douglas Beuerman, Boulder Creek, CA US
Patent application number | Description | Published |
---|---|---|
20160093445 | VACUUM VARIABLE CAPACITOR - A vacuum variable vapacitor includes a pre-vacuum enclosure for reducing a pressure differential across the bellows, wherein a drive is disposed outside the enclosures of the vacuum variable capacitor. The vacuum force load on the drive system can thereby be reduced, allowing faster movement of the movable electrode, faster capacitance adjustment of the vacuum variable capacitor and longer lifetimes of the device. | 03-31-2016 |
20160111218 | VACUUM VARIABLE CAPACITOR - A vacuum variable capacitor includes a pre-vacuum enclosure for reducing a pressure differential across the bellows. The vacuum force load on the drive system can thereby be reduced, allowing faster movement of the movable electrode, faster capacitance adjustment of the vacuum variable capacitor and longer lifetimes of the device. | 04-21-2016 |
Jamie Beuerman, Kanata CA
Patent application number | Description | Published |
---|---|---|
20150087315 | CARRIER AGGREGATION SCELL SELECTION FOR LTE-A - Systems and methods for Secondary Cell (sCell) selection for wireless devices operating according to a carrier aggregation scheme in a cellular communications network are disclosed. In one embodiment, a network node obtains a list of potential sCells for a wireless device. The network node blindly selects an sCell for the wireless device from the list of potential sCells. The network node then configures the wireless device with the selected sCell. Blindly selecting the sCell for the wireless device makes it possible to avoid the use of measurement gaps and reduce throughput loss, according to some embodiments. | 03-26-2015 |
20150223125 | SECONDARY CELL SELECTION BASED ON GEOGRAPHIC SIGNATURES - Systems and methods for Secondary Cell (sCell) selection for wireless devices operating according to a carrier aggregation scheme in a cellular communications network are disclosed. In one embodiment, a network node in the cellular communications network obtains geographic signatures for a number of candidate sCells. The geographic signatures include a geographic signature for each candidate sCell that approximates a coverage area of the candidate sCell. The network node obtains position information for a wireless device and then selects one or more sCells for the wireless device from the candidate sCells based on the geographic signatures for the candidate sCells and the position information for the wireless device. The network node then configures the selected sCell(s) for use by the wireless device according to a carrier aggregation scheme. Using this process, sCell selection is performed, in some examples, without measurement gaps and without disabling an s-Measure parameter. | 08-06-2015 |
Roger Beuerman, Singapore SG
Patent application number | Description | Published |
---|---|---|
20090258828 | INVESTIGATION OF MUCOSA DRYNESS CONDITIONS - The present invention relates to diagnosis and/or treatment of medical conditions. The present invention relates to new method of diagnosing dry mucosa condition in a subject. The condition may be dry eye. The present invention also provides a method to monitor the efficacy of a treatment of a dry mucosa condition, a method of treating a dry mucosa condition and/or a diagnostic kit for a dry mucosa condition. | 10-15-2009 |
20100048469 | ANTIMICROBIAL PEPTIDES - There is provided at least one isolated antimicrobial peptide, wherein the peptide is a linear analog of hBD3 or a fragment thereof. In particular, there is provided a linear analog of hBD3 wherein the peptide has a reduced cytotoxicity to at least one cell compared to the wild type hBD3. | 02-25-2010 |
20150225454 | TETRABRANCHED PEPTIDES AND ANALOGUES AS A NEW CLASS OF ANTIMICROBIALS AND THEIR PREPARATION THEREOF - An isolated peptide tetramer includes the formula [(RGRKVVRR) | 08-13-2015 |
Roger Wilmer Beuerman, Singapore SG
Patent application number | Description | Published |
---|---|---|
20150231199 | PEPTIDES AND THEIR USES - Disclosed are antimicrobial peptides. Also disclosed are methods of treating bacterial infection and fungal infection and a method of removing biofilm. Also disclosed is the use of these peptides. | 08-20-2015 |